Forget Facebook and Apple and buy cheap BANG stocks
Critical information for the U.S. trading day
Get ready to hit the ground running.
All Posts in "Markets"
Stock market closes firmly lower as surge in bond yields sparks equity revaluation
S&P 500, Nasdaq book worst day since June
New cloud over Super Micro adds to its dark relationship with Wall Street
Opinion: Report of Chinese spy chip adds to company’s accounting troubles
Why investors shouldn’t fear the dominance of FAANG stocks
Concentration is ‘a feature and not a bug’ of the stock market
Asian markets continue to sink, led by tumbling tech stocks
Nikkei sags as yen gains; Apple suppliers fall in Hong Kong, Taiwan
Guardant Health soars almost 70% in first day of trading
Guardant Health shares popped almost 70 percent in their first day of trading on Thursday.
The Silicon Valley oncology company, backed by SoftBank, sold 12.5 million shares at $19 in its initial public offering. The stock was up more than 80 percent in mid-afternoon trading but later pared some of those gains, closing up 69.47 percent at $32.20 per share.
JP Morgan downgrades China stocks, predicts ‘full-blown trade war’ with US
J.P. Morgan is getting less optimistic about the trade conflict between the U.S. and China.
The firm lowered its rating for Chinese equities to neutral from overweight, predicting the escalating trade war between the countries will affect China’s economy next year.
Facebook stock is worth the risk, Mark Mahaney says
Facebook will come back stronger than ever from its data privacy scandals, so invest now, RBC Capital Markets’ lead internet analyst told CNBC on Thursday.
Dow stock Intel could be on the verge of a big breakout
Trader sees Intel breaking through to new highs
Intel has been lagging the semis as a whole this year, but TradingAnalysis.com founder Todd Gordon says the charts are pointing to a breakout for the chipmaker.
Never pay checked baggage fees again with these travel hacks
It’s getting more expensive to bring bags on planes, but these simple tips can help you avoid those costs
‘We’re pretty prolific’: Lilly Catalyze360 looks to connect with emerging biotechs across ‘all areas’
FDA clears its first at-home blood test for syphilis
FDA clears Cresilon’s bloodstopping gel for severe wounds
Pfizer, BioNTech’s combo mRNA shot is latest to be defeated by influenza strain B
FDA allows BioNTech-MediLink ADC trial to resume with lower, safer doses
Polyrizon pays $3M for license to SciSparc’s preclinical cannabinoid pain therapy
GI robotics developer Neptune Medical raises $97M, launches Jupiter Endovascular
Genentech to shut down cancer immunology research department amid broader R&D rethink
Weekly Market Review – November 23, 2024
In the wake of Céline Dion’s diagnosis and comeback, stiff-person syndrome researchers and advocates march toward a cure